In another noteworthy investigation, SFN combined with CB-5083 countered resistance and reduced cell proliferation by inactivating NF-κB in HCT116 CRC cells resistant to CB-5083 [96]. The gene discussed is NFKB1; the disease is colorectal carcinoma.